Pharmacy news

• Clues Emerge for Lower Adherence to Oral Myeloma Therapy

  16-05-2026 16:54 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy Continuumfigure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }K Davis/peopleimages.com – stock.adobe.comBy Gina ShawPatients with
  
  Read more

• Trauma and Resilience Shape Medication Adherence in Lupus

  16-05-2026 16:51 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy Continuumfigure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }Andrey Znamensky – stock.adobe.comBy Gina ShawNearly half of patient
  
  Read more

• Novel AST Dx Based on Biofilm Cell Memory Shows Promise in Hard-to-Treat Drug-Resistant Infections

  16-05-2026 13:46 via pharmacypracticenews.com
  By Gina ShawA novel antimicrobial susceptibility testing (AST) diagnostic, AtbFinder, based on the response of preserved patient-specific polymicrobial biofilm behavior, achieved clinically effective therapy for hard-to-treat, multidrug-resistant (MDR) infections and outperformed standard AST, in findings presented at the newly combined Society of Infectious Disease Pharmacists (SIDP) and Making a Difference in Infectious Disease (MAD-ID) 2026 conference in Orlando, Florida.figure { display:inli
  
  Read more

• Pharmacist-Led IV-to-Oral Conversion Yields LOS, Cost Benefits

  16-05-2026 09:54 via pharmacypracticenews.com
  By Gina ShawA pharmacist-led IV-to-oral conversion protocol significantly improved length of stay (LOS) and cost outcomes, particularly in higher-acuity populations such as diabetes and sepsis, reported investigators from Memorial Hermann Greater Heights Hospital, in Houston, at the newly combined Making a Difference in Infectious Diseases (MAD-ID) 2026 and Society of Infectious Diseases Pharmacists annual conference, in Orlando, Florida.figure { display:inline-block; margin:0.5em; border:thin s
  
  Read more

• Advertisement

Follow @newsl_pharmacy on Twitter!